Interventional oncology company Delcath Systems Inc. (DCTH) is advancing toward a key milestone in its clinical and commercial trajectory with the upcoming oral presentation of data from the investigator-initiated CHOPIN Phase 2 trial at the 2025 European Society for Medical Oncology or ESMO Annual Congress.
The presentation will spotlight results from the investigator-initiated CHOPIN Phase 2 trial, a randomized study evaluating a novel combination therapy for metastatic uveal melanoma (mUM), a rare and aggressive form of eye cancer with limited treatment options.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.